Frequent nuclear ?-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation
- 14 March 2001
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 194 (1) , 59-67
- https://doi.org/10.1002/path.856
Abstract
Focal squamous differentiation is a common feature of endometrioid endometrial and ovarian carcinomas (E-Em and E-Ova Cas). A close association between mutated β-catenin accumulation and alteration in cellular morphology has recently been demonstrated in murine L cell lines. To clarify the possible role of β-catenin abnormalities and changes in tumour morphology, 60 grade (G) 1 or G2 E-Em Cas with areas of squamous differentiation (SqD), including morules and squamous metaplastic (SqM) foci, as well as 32 G1 or G2 tumours without such lesions, were investigated and the results compared with findings for c-jun and wnt-1 expression. Twenty-three E-Ova Cas, with and without SqD lesions, were also examined. In E-Em Cas, frequent nuclear β-catenin accumulation was observed in 22 (84.6%) of 26 tumours with morules and 15 (45.5%) of 33 with SqM foci, in contrast to 4 (12.5%) of 32 without such lesions. Similar findings were also noted for mutations in exon 3 of the β-catenin gene, involving codons 32, 33, 34, 37, 41, and 45, the single nucleotide substitutions being identical between SqD and the surrounding carcinoma tissue in most informative cases. The mutations were positively related to nuclear immunopositivity, but inversely to membrane expression, while there was no association with the status of c-jun or wnt-1. These E-Ova Cas, nuclear β-catenin accumulation and mutations were limited to tumours with SqD features, independent of c-jun and wnt-1 status. These data indicate that β-catenin abnormalities are relatively common in E-Em and E-Ova Cas with SqD features, implying a role in the squamous differentiation of tumour cells, not necessarily related to c-jun and/or wnt-1 status. Copyright © 2001 John Wiley & Sons, Ltd.Keywords
This publication has 19 references indexed in Scilit:
- Up-regulation of pS2 expression during the development of adenocarcinomas but not squamous cell carcinomas of the uterine cervix, independently of expression of c-jun or oestrogen and progesterone receptorsThe Journal of Pathology, 2000
- β-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus InfectionThe American Journal of Pathology, 1999
- Nuclear Accumulation of Mutated β-Catenin in Hepatocellular Carcinoma Is Associated with Increased Cell ProliferationThe American Journal of Pathology, 1999
- β-Catenin Expression Pattern in Stage I and II Ovarian CarcinomasThe American Journal of Pathology, 1999
- β-Catenin regulates expression of cyclin D1 in colon carcinoma cellsNature, 1999
- Target genes of β-catenin–T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomasProceedings of the National Academy of Sciences, 1999
- Mutations of the β‐Catenin Gene in Endometrial CarcinomasJapanese Journal of Cancer Research, 1999
- WISP genes are members of the connective tissue growth factor family that are up-regulated in Wnt-1-transformed cells and aberrantly expressed in human colon tumorsProceedings of the National Academy of Sciences, 1998
- Activation of the Wnt Signaling Pathway: A Molecular Mechanism for Lithium ActionDevelopmental Biology, 1997
- Signal transduction by β-cateninCurrent Opinion in Cell Biology, 1995